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Summary  
The objective of this study was to investigate the expression and extracellular distribution of fibrillar collagen types 
I, II, and III in early stage osteoarthritic cartilage in order to elucidate matrix gene expression and cell differentiation 
in early phases of the disease. Arthroscopically, derived specimens of early stage osteoarthritic articular cartilage were 
analyzed by histochemistry, immunohistochemistry and by in situ hybridization and compared with normal articular 
cartilage samples. In normal articular cartilage no significant mRNA expression of any of the investigated collagen 
types was found. In early stage osteoarthritic specimens, a strongly enhanced mRNA expression of the major cartilage 
matrix component type II collagen was detected. Additionally, a focal onset of type III, but not ype I collagen 
expression was observed. Thus, besides activation of matrix synthesis, the modulation of the chondrocytic phenotype 
is likely to play a distinct role in the cellular esponse in the early phases of the degenerative process in osteoarthritis. 
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Introduct ion 
THE EARLY events of osteoarthritic cartilage 
degeneration are not well understood. The investi- 
gation of these stages in man is, for material 
reasons, rather difficult and mainly restricted to 
post-mortem histological studies [1-3]. In fact, 
so far all studies that have analyzed human 
osteoarthritic cartilage with biochemical or mol- 
ecular biological techniques, have used material 
from less damaged, peripheral areas of late-stage 
osteoarthritic ar t i lage [4-7]. Modern imaging 
techniques like magnetic resonance imaging 
(MRI), however, provide more and more detailed 
insights into early osteoarthritic artilage de- 
generation [8-10]~ The value of direct visualization 
and subsequent histological evaluation of the joint 
cavity by arthroscopy has been emphasized by 
various investigations [11, 12]. In the present 
study, we applied immunohistochemlcal and in situ 
hybridization techniques a  a supplementary 
approach to standard histochemical nalysis for a 
more extensive evaluation of such samples. We 
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used analysis of expression patterns of fibrillar 
collagen types I, II, and III as classical markers of 
chondrocyte activity and differentiation in vivo 
and in vitro [13]: Type II collagen is the typical 
gene product of active functional chondrocytes. 
Type I collagen, in contrast, is the major collagen 
type expressed by so-called dedifferentiated chon- 
drocytes in vitro, which display a completely 
different phenotype [14-16]. The onset of collagen 
type III expression was recently described for 
osteoarthritic chondrocytes in late-stage samples 
[7]. The aim of our study was to evaluate, whether 
similar phenomena re also present in earlier 
stages of osteoarthritic artilage degeneration, 
and thus, in the development of the disease. The 
applied methodology enabled the analysis of these 
parameters, even with very small amounts of 
material available. 
Material and Methods 
TISSUE SELECTION 
The study was performed on a series of 12 biopsy 
specimens from eight patients undergoing arthro- 
scopical surgery because of painful intra-articular 
lesions of the knee joints. The patients were 
selected (age range: 42-60 years) according to the 
clinical criteria for osteoarthritis of  the knee 
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defined by the ACR [17]. Cases of known 
rheumatoid arthritis, secondary osteoarthritis 
due to severe trauma, and late stage primary 
osteoarthritis were excluded from the study. 
Articular cartilage was considered to be in an 
early stage of osteoarthritis, if macroscopically: 
(1) mild to moderate cartilage damage was seen, 
(2) cartilage damage was restricted to limited areas 
within the joint, and (3) no sites of full-depth 
cartilage erosion were seen. For ethical reas~)ns, 
arthroscopical specimens were only taken from 
regions of cartilage that had to be removed for 
therapeutic purposes. Thus, the size of the 
specimens was on the average about 3 mm ~. The 
cartilage pieces were removed with microforceps 
during the arthroscopical procedure. Only samples 
of the weight-bearing areas (femoral condyles and 
tibial plateau) were taken for the study. Special 
care was taken to distinguish original cartilage 
from newly-formed cartilage at sites of osteophyte 
formation, and only the former was used for this 
study. 
Eight macroscopically and histologically normal 
samples were obtained from knee amputation or 
autopsies not later than 24 h post mortem (age 
range: 52-65 years). All samples were analyzed for 
the presence of the superficial (uppermost 10% of 
the normal articular cartilage with mainly flat 
cells), middle (mostly single rounded cells) and 
deep zones (lower 50% of the normal articular 
cartilage with rounded cells mainly arranged in 
columns) [Fig. l(a)]. The grading was performed 
according to Mankin et al. [4], however the 
evaluation of changes of the tidemark was 
excluded. Latter modification was necessary be- 
cause only one full-thickness sample was obtained 
by arthroscopy (for ethical reasons). 
TISSUE PREPARATION AND HISTOCHEMISTRY 
Cartilage slices were fixed with 4% 
paraformaldehyde immediately after removal, 
embedded in paraffin wax, and 5 pm sections were 
cut. From all samples hematoxylin-eosin and 
toluidine blue stainings were performed on serial 
sections. The latter were used to estimate the 
content of proteoglycans. 
IMMUNOHISTOCHEMISTRY 
Deparaffinized sections were incubated with 
testicular hyaluronidase [2 mg/ml, phosphate 
buffered saline (PBS), pH5, 30min at room 
temperature] and pronase (lmg/ml, PBS, pH 7.3, 
30 min at room temperature). Primary antibodies 
were incubated for I h at 37°C and visualized using 
alkaline phosphatase-labeled s condary antibodies 
and 3-hydroxy-2-naphylacid 2,4-dimethylanilide as 
color substrate. Nuclei were counterstained with 
hematoxylin. Monoclonal antib(~dies against an 
epitope in the CB 10 fragment of type II collagen 
(CII D3) were kindly provided by Dr R. Holmdahl 
(University of Uppsala, Sweden) [18]. Polyclonal 
rabbit antisera against ype III procollagen were 
kindly provided by Dr Gfinzler (Hoechst Co, 
Frankfurt, FRG). Preparation and specificity of 
this antibody are described in [19]. 
a • ~ • b ¸ 
FIG. 1. Normal (a) and early osteoarthritic (b) cartilage stained for proteoglycans. (toluidine blue; s: superficial zone; 
m: middle zone; d: deep zone; magnification: ×70; a: femoral condyle; Mankin's grade 1; 60 years; male; b: femoral 
condyle; Mankin's grade 5; 55 years;• female). 
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PREPARATION OF RNA-PROBES 
For specific RNA probes, suitable fragments of 
human collagen chains al(I), ul(II), and c4(III) 
mRNA were selected and recloned into pGEM 
vectors (Promega), as described in detail elsewhere 
[7, 20]: pHCGIN contains a 207bp fragment of 
collagen ~1(I) (N'-terminal globular domain), 
pHCG 2 a 435bp fragment of collagen al(II) 
(3'-untranslated sequence), and pHCG~3 a 294 bp 
fragment of collagen c~l(III) (mainly 3'-terminal 
globular domain). The constructs were linearized 
and transcribed in vitro using T7 and SP6 
RNA-polymerase (both Promega) to generate 
ant isense and sense transcripts, respectively. The 
RNA-probes were labeled with 150 ~Ci [~-3sS]-UTP 
(1200Ci/mmo], New England Nuclear (NEN), 
Dreireich, F.R.G.) per 0.5-1 pg of template DNA to 
a specific activity of up to 1,2xl09cpm/mg and 
un-incorporated nucleotides eparated by alcohol 
precipitation. 
IN  S ITU HYBRIDIZATION 
In situ hybridization was performed as described 
in detail elsewhere [20]. Briefly, deparaffinized and 
rehydrated sections were digested with proteinase 
K, post-fixed, washed, acetylated, washed again, 
and dehydrated. The sections were hybridized for 
12-16 h at 43°C. After hybridization the tissue 
sections were washed 40°C 2xSSC/0.5% ~- 
mercaptoethanol and 40°C 0.5xSSC/0.5% ~- 
mercaptoethanol, treated with RNases  A and T1, 
washed again for 2 h 45°C 2 x SSC/50% formamide/ 
0.5% ~-mercaptoethanol. After three times in 
0.1xSSC at room temperature the slides were 
dehydrated. 
Autoradiography was performed (Kodak NTB-2 
nuclear track emulsion) for 3-10 days at 4°C and 
sections counterstained in 5% Giemsa dye. 
CONTROL EXPERIMENTS 
The specificity of the cDNA probes and 
antibodies used has been tested extensively in 
previous studies [7, 21]. A probe for 18S rRNA was 
used as a positive control for preservation of the 
RNA content in the samples during the technical 
procedures [Fig. 2(f)]. Sense transcripts were used 
as negative controls, and only produced minimal 
background staining [Fig. 2(g), 3(f)]. For immuno- 
histochemistry, primary or secondary antibodies 
were omitted and replaced by PBS. Additionally, 
non-immune serum was used instead of the primary 
antibody at the same dilution. 
Resu l ts  
Normal articular cartilage had a whitish 
appearance and showed no signs of surface 
fibrillation or cartilage erosion (Mankin's grade 
0-1) [Fig. l(a)]. 
Macroscopically, the cartilage of arthroscopical 
specimens was soft, fissured, and often slightly 
yellowish. Histologically, the samples were rather 
heterogeneous in appearance. The superficial zone 
was lost and the cartilage showed clefts and clones 
of chondrocytes, as well as loss of proteoglycans in
the middle zone [Fig. l(b)]. The Mankin's grade [4] 
ranged from low to intermediate in the various 
specimens (Mankin's grade 3-6). 
ACTIVATION OF TYPE II COLLAGEN EXPRESS ION 
(TABLE I) 
Normal cartilage specimens howed no signifi- 
cant mRNA staining for collagen type II, and 
immunohistochemically, an even staining pattern 
for type II collagen protein was observed (not 
shown). 
In most specimens of early osteoarthrit ic 
cartilage (nine out of 12), in situ hybridization 
analysis of mRNA expression for collagen type II 
revealed positive staining in a subset of chondro- 
cytes [Fig. 2(b),(c), Fig. 3(a)], whereas other 
specimens and other areas of the same specimen 
did not show any staining of collagen type II 
mRNA [Fig. 3(b)]. There was no difference seen in 
levels of expression of type II collagen mRNA 
Table I 
Expression levels of collagen type I [ctl(I)], type I I  [~l(II)] and type I I I  mRNA [cd(III)] in 
a typical case of early osteoarthritic artilage in the investigated specimens 
Cartilage zone* Proteoglycan content col(I) mRNA ~l(II) mRNA cel(III) mRNA 
Upper middle Reduced - - - 
Lower middle Slightly reduced - + + + t 
Deep Normal - - - 
Normal samples revealed no mRNA signals for any of the investigated collagen types. 
*The superficial zone was no longer present in the samples. 
tScattered positive cells. 
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FIG. 2. (a)-(c) Positive expression of ~l(II) collagen mRNA in chondrocyte clusters [(a) bright-field micrograph; (b) 
dark-field] and single cells (c). (d) Type II collagen protein immunostaining revealed a very irregular, pericellularly 
enhanced staining. (e) Type III collagen protein immunostaining with mostly pericellular signals. (f) Control in situ 
hybridization with a probe for 18S rRNA. (g) Control in situ hybridization using a sense control probe [ul(II) collagen]. 
[(a), (d), (e) bright-fields; (b), (c), (e) dark-fields; (a)-(f) magnification: x170; (a)-(f) emoral condyle; Mankin's grade 3; 
66 years; male]. 
between single cells or chondrocyte clusters 
[Fig. 2(a),(b),(c)]. Overall, the type II collagen 
mRNA positive cells were scattered in the middle 
zone (seven out of nine); in only two samples were 
most cells of the middle zone positive. In the 
proteoglycan depleted areas and in the deep 
zone--if present within the specimens--no stain- 
ing for ~l(II) mRNA was seen in any of the cases. 
The immunohistochemical nalysis of the 
arthroscopical specimens with the monoclonal 
antibody to type II collagen showed an irregular 
staining pattern compared with specimens of 
normal cartilage. Enhanced staining was seen 
pericellularly [Fig. 2(d), 3(c)] in areas, where ~l(II) 
mRNa expression was shown by in situ hybridiz- 
ation analysis [Fig. 3(a)]. In contrast, other areas 
retained the even staining pattern for collagen 
type II throughout the extraceltular matrix 
[Fig. 3(e)]. In many samples, loss of epitope 
staining for type II collagen was observed in the 
interterritorial matr ix [Fig. 3(d)]. 
COLLAGEN TYPES I AND III (TABLE I) 
In situ hybridization analysis with the probe for 
~l(III) collagen revealed positive cells in a 
minority of early stage specimens [four out of 12; 
Fig. 3(c)], whereas most osteoarthritic hondro- 
cytes were negative. ~l(III) mRNA positive 
chondrocytes were scattered and confined to the 
upper part of the middle zone. On the average, the 
signals were less intense than those found for al(II) 
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FIG. 3. In situ hybridization analysis revealed strongly positive (a), but also negative (b) cells for ul(II) collagen mRNAs 
in the same samples. Only moderately positive cells for ul(III) collagen mRNA were detected focally (c). The control 
in situ hybridization using a sense transcript [ul(II)] was negative (f). Immunohistochemically, areas with (d) and 
without (e) pericellular strongly enhanced and reduced interterritorial staining for collagen type II were seen. [(a), 
(b), (c), (f) darGfields; magnification: x170; (a), (f) femoral condyle; Mankin's grade 5; 47 years; male]. 
mRNA [Fig. 3(a)]. The expression of type III 
collagen by the chondrocytes of the middle zone 
could be confirmed by the pericellular immunohis- 
tochemical staining of type III collagen protein 
[Fig. 2(e)]. In contrast to type III collagen, no 
mRNA for type I [ul(I)] collagen could be detected 
in the samples (not shown). Normal articular 
cartilage specimens did not show any mRNA 
signals for collagen chains ~1(I) and al(III) (data 
not shown). 
Discuss ion  
Collagen expression and distribution is of 
particular interest in understanding cartilage 
matrix destruction and repair because, type II 
collagen in particular, together with the large 
aggregating proteoglycan, aggrecan, represent the 
major constituents of the extracellular matrix of 
hyaline articular cartilage [22]. 
In normal articular cartilage, no significant 
mRNA levels were found for collagen type II. This 
may be in part due to the lack of sensitivity of the 
in situ hybridization method compared with, for 
example, northern blot analysis [23], but mainly 
reflects the very low turnover of the collagen type 
II in normal articular cartilage [24]. 
In most of the early-stage osteoarthrit ic speci- 
mens investigated, an enhanced expression of 
collagen type II was detected indicating the 
attempt by the osteoarthritic chondrocytes to 
reconstitute the impaired extracellular matrix by 
the resynthesis of its major components. This is 
consistent with data obtained in animal models of 
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early osteoarthritis, in which an enhanced syn- 
thesis of collagen type II was found biochemically 
[25]. Also the nonhomogenous immunohisto- 
chemical staining of the osteoarthrit ic cartilage 
matrix for type II collagen reflects the matrix 
destruction and remodeling process taking place in 
all phases of osteoarthrit is [26]. It is noteworthy 
that only a subset of the chondrocytes, usually in 
the middle zones, expressed type II collagen 
mRNA, underl ining the part icular behavior and 
role of these middle zone chondrocytes in the 
disease process [27]. 
As well as being the major components of, the 
cartilage matrix collagens in part icular the 
investigated collagen types I, II, and III, can serve 
as markers for the differentiation of chondrocytes 
as shown by many studies in vivo and in vitro 
(for review see [13]). Our analysis of early stage 
osteoarthrit ic arti lage showed the onset of the 
expression and the pericellular deposition of type 
IIi collagen in a subset of osteoarthrit ic chondro- 
cytes. These findings indicate that the cell 
differentiation pattern seen in late stage os- 
teoarthrit ic samples [7] can be already observed in 
early stage osteoarthrit ic chondrocytes. The fact 
that no type I collagen mRNA expression was 
observed is in principle consistent with data 
obtained on the protein level from human and 
animal model samples, which were not able to 
show significant amounts of collagen type I in 
osteoarthrit ic carti lage [5, 28-30]. Type I collagen, 
however, would be typical for the so-called 
dedifferentiated chondrocytes as found in vitro in 
certain culture conditions [14, 15, 31, 32]. Thus, 
'dedifferentiation' of osteoarthrit ic hondrocytes 
[33] did not seem to be a major feature at least in 
our samples. 
For ethical reasons only parts of the cartilage, 
which had to be removed for therapeutic reasons, 
were taken and investigated. The very limited 
amount of material available makes the analysis 
by usual biochemical or Northern blot RNA 
analysis methods nonfeasible. The application of 
in situ detection methods at the mRNA (in situ 
hybridization) and protein level (immunohisto- 
chemistry) to analyze the expression and distri- 
bution of extracellular proteins is an efficient way 
to overcome the problem of the very limited 
material available. These techniques allow de- 
tailed studies of earlier stages of the osteoarthrit ic 
cartilage degeneration, and thus, enable us to 
understand more about the pathogenic mechan- 
isms involved in init iation and progress of the 
disease. Herein, more studies on larger numbers of 
arthroscopic specimens and on other matrix 
components such as proteoglycans, as well as of 
factors regulating the synthetic activity of chon- 
drocytes will be necessary. 
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